Revenue
18.4 million USD
2025 · USD
Exact inputs and evidence
- Revenue: 18406849 USD Source
Market value is not computed: this company’s US price is per depositary share, not per ordinary share.
Annual consolidated revenue for 2025: about USD 18.41M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 15.8M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-21.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
6717787 USD
12500000 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-18.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 15.8 million
–
Current period
USD 18.41 million
–
18406849 − 15796983 = 2609866 USD
15796983 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source18406849 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.61 million
–
Current period
−USD 5.45 million
–
-5446252 − 1606489 = -7052741 USD
1606489 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5446252 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.58 million
–
Current period
−USD 1.89 million
–
-1890612 − 1579383 = -3469995 USD
1579383 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-1890612 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 25,759
–
Current period
USD 192,531
–
192531 − 25759 = 166772 USD
25759 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source192531 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | 6652308 | 6002178 Derived | 650130 | 112575 Derived | 537555 | 1220863 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 12610873 | 11225605 Derived | 1385268 | 32757 Derived | 1352511 | 181117 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 15796983 | 14509347 Derived | 1287636 | -318853 Derived | 1606489 | 1553624 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 18406849 | 24224283 Derived | -5817434 | -371182 Derived | -5446252 | -2083143 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Revenue | 6652308 |
|
| 2023 | Revenue | 12610873 |
|
| 2024 | Revenue | 15796983 |
|
| 2025 | Revenue | 18406849 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | 89.6% |
|
| 2024 | Year over year | 25.3% |
|
| 2025 | Year over year | 16.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022 | Operating margin | 9.8% |
|
| 2023 | Operating margin | 11% |
|
| 2024 | Operating margin | 8.2% |
|
| 2025 | Operating margin | -31.6% |
|
| 2022 | Net margin | 8.1% |
|
| 2023 | Net margin | 10.7% |
|
| 2024 | Net margin | 10.2% |
|
| 2025 | Net margin | -29.6% |
|
| 2022 | Free cash flow margin | 18.4% |
|
| 2023 | Free cash flow margin | 1.4% |
|
| 2024 | Free cash flow margin | 9.8% |
|
| 2025 | Free cash flow margin | -11.3% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Operating cash flow | 1239028 |
|
| 2023 | Operating cash flow | 400238 |
|
| 2024 | Operating cash flow | 1579383 |
|
| 2025 | Operating cash flow | -1890612 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2022 | Free cash flow | 1220863 |
|
| 2023 | Free cash flow | 181117 |
|
| 2024 | Free cash flow | 1553624 |
|
| 2025 | Free cash flow | -2083143 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2023 | Liabilities / assets | 44.1% |
|
| 2024 | Liabilities / assets | 44.4% |
|
| 2025 | Liabilities / assets | 34.9% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2022-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2023 | Current assets / current liabilities | 1.33× |
|
| 2024 | Current assets / current liabilities | 1.62× |
|
| 2025 | Current assets / current liabilities | 2.11× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | USD 537,555 Exact valueExact value: 537555 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.24 million Exact valueExact value: 1239028 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 18,165 Exact valueExact value: 18165 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.22 million Calculation and evidence1239028 − 18165 USD Exact free cash flow: 1220863 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | USD 1.35 million Exact valueExact value: 1352511 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 400,238 Exact valueExact value: 400238 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 219,121 Exact valueExact value: 219121 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 181,117 Calculation and evidence400238 − 219121 USD Exact free cash flow: 181117 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | USD 1.61 million Exact valueExact value: 1606489 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.58 million Exact valueExact value: 1579383 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 25,759 Exact valueExact value: 25759 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.55 million Calculation and evidence1579383 − 25759 USD Exact free cash flow: 1553624 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 5.45 million Exact valueExact value: -5446252 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.89 million Exact valueExact value: -1890612 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 192,531 Exact valueExact value: 192531 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.08 million Calculation and evidence-1890612 − 192531 USD Exact free cash flow: -2083143 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
31 filings · 353 latest values · 353 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001991592, 1991592, INLF, edgar:1991592
Also known as INLIF LIMITED, INLIF Ltd